Council of Councils Meeting
May 14, 2013
Slide Presentations
-
CoC-051413-DPCPSI-Update.pdf (1.53 MB)
James M. Anderson, M.D., Ph.D., Director, Division of Program Coordination, Planning, and Strategic Initiatives -
CoC-051413-NCF-Epigenomics-Program.pdf (1.49 MB)
John Satterlee, Ph.D., Epigenomics Program Co-coordinator, National Institute on Drug Abuse/NIH -
CoC_051413_Remarks_By_Director.pdf (1.54 MB)
John Stamatoyannopoulos, M.D., Associate Professor of Genome Sciences and Medicine, School of Medicine, University of Washington, Seattle, Washington -
CoC_051413_Remarks_By_Director.pdf (1.54 MB)
Francis S. Collins, M.D., Ph.D. -
CoC-051413-Concept-Clearance.pdf (814.22 KB)
James M. Anderson, M.D., Ph.D., Director, Division of Program Coordination, Planning, and Strategic Initiatives,
Elizabeth Wilder, Ph.D., Director, Office of Strategic Coordination, DPCPSI -
CoC-051413-Concept-Clearance.pdf (814.22 KB)
Oleg Mirochnitchenko, Ph.D., Division of Comparative Medicine (DCM), Office of Research Infrastructure Programs (ORIP), DPCPSI/OD/NIH -
CoC-051413-Operating-Prodecures.pdf (88.6 KB)
James M. Anderson, M.D., Ph.D., Director, Division of Program Coordination, Planning, and Strategic Initiatives -
CoC-051413-Pioneer-Award-Program-DP1.pdf (321.09 KB)
James M. Anderson, M.D., Ph.D., Director, Division of Program Coordination, Planning, and Strategic Initiatives -
CoC-051413-ODP.pdf (886.93 KB)
David M. Murray, Ph.D., Associate Director for Prevention, Director, Office of Disease Prevention